Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient

Panic disorder (PD) being one of the most intensively investigated anxiety disorders is considered a heterogeneous psychiatric disease which has difficulties with early diagnosis. The disorder is recurrent and usually associated with low remission rates and high rates of relapse which may exacerbate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zulfarina, Mohamed S., Syarifah-Noratiqah, Syed-Badrul, Nazrun, Shuid A., Sharif, Razinah, Naina-Mohamed, Isa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478076/
https://www.ncbi.nlm.nih.gov/pubmed/30905115
http://dx.doi.org/10.9758/cpn.2019.17.2.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478076/
https://www.ncbi.nlm.nih.gov/pubmed/30905115
http://dx.doi.org/10.9758/cpn.2019.17.2.145

Ejemplares similares